iEmoji Feeds @Arturo Loaiza-Bonilla, MD MSEd (DrBonillaOnc)

1.

DrBonillaOnc
TONIGHT 10.03.22 at 8pm ET Join me to discuss treatment in previously tx EGFRmut+ #NSCLC!

Join us here on… twitter.com/i/web/status/1…
Retweet of status by @n8pennell
08 Oct 22 copy & paste +upvote -downvote 💥TONIGHT💥 10.03.22 at 8pm ET Join me to discuss treatment in previously tx EGFRmut+ #NSCLC! 💬Join us here on… https://t.co/DiQr0QDtNM

2.

DrBonillaOnc
1. How often are you using anti-PD-1 therapy in patients w/ PD-L1 CPS <5

Major biomarkers in G/GEJ cancers (frequ… twitter.com/i/web/status/1…
Retweet of status by @OncBrothers
30 Sep 22 copy & paste +upvote -downvote 1. How often are you using anti-PD-1 therapy in patients w/ PD-L1 CPS &lt;5❓ Major biomarkers in G/GEJ cancers (frequ… https://t.co/zyd4W6lkwE
3.
DrBonillaOnc
Amplifying this GitHub thread on cryoDRGN integration with @UCSFChimeraX! Please comment if you have any feedbac… twitter.com/i/web/status/1…
Retweet of status by @ZhongingAlong
06 Sep 22 copy & paste +upvote -downvote Amplifying this GitHub thread on cryoDRGN ❄️🐉integration with @UCSFChimeraX! Please comment if you have any feedbac… https://t.co/JBXMwxLoPZ
4.
DrBonillaOnc
Our program chairs, @DrBonillaOnc and @DrShaymaKazmi, invite you to join them at the 2022 ASCO Direct Philadelphia… twitter.com/i/web/status/1…
Retweet of status by @TotalHealthConf
17 Jun 22 copy & paste +upvote -downvote Our program chairs, @DrBonillaOnc and @DrShaymaKazmi, invite you to join them at the 2022 ASCO Direct™ Philadelphia… https://t.co/PwadqsOxJN
5.
DrBonillaOnc
It is time. @ASCO Abstracts just dropped! #ASCO22 twitter.com/asco/status/15…
Retweet of status by @rachnatshroff
26 May 22 copy & paste +upvote -downvote It is time. @ASCO Abstracts just dropped! 🎉🥳👏 #ASCO22 https://t.co/10M7yNhO7i
6.
DrBonillaOnc
#cholangiocarcinoma
Can I ask for your opinion via poll

Young Pt,PS
Resected poorly diff intra hep… twitter.com/i/web/status/1…
Retweet of status by @MPishvaian
24 Mar 22 copy & paste +upvote -downvote #cholangiocarcinoma🗺️👨‍👩‍👦‍👦 🙏Can I ask for your opinion via poll❓ ➡️Young Pt,👍PS ➡️Resected poorly diff intra hep… https://t.co/fCPFb8OmnS
7.
DrBonillaOnc
“MILDER” will not save us from overwhelmed hospitals. NYC #COVID19 admissions up 4x in a month. Even if it’s… twitter.com/i/web/status/1…
Retweet of status by @DrEricDing
22 Dec 21 copy & paste +upvote -downvote ⚠️“MILDER” will not save us from overwhelmed hospitals. NYC #COVID19 🏥admissions up ⬆️4x in a month. ➡️Even if it’s… https://t.co/7A8LGVJ1Vd
8.
DrBonillaOnc
Promising. POST-OP ctDNA had PPV of 100% and NPV of 87% in locally advanced rectal cancer treated with pre-op che… twitter.com/i/web/status/1…
Retweet of status by @HKennecke
27 Sep 21 copy & paste +upvote -downvote Promising. POST-OP ctDNA 🧬 had PPV of 100% and NPV of 87% in locally advanced rectal cancer treated with pre-op che… https://t.co/wnlpxhMmUM
9.
DrBonillaOnc
Researchers at University of Washington developed a way for #3Dprinted objects to connect to #WiFi WITHOUT electro… twitter.com/i/web/status/1…
Retweet of status by @GlenGilmore
18 May 21 copy & paste +upvote -downvote Researchers at University of Washington developed a way for #3Dprinted objects to connect to #WiFi 📶WITHOUT electro… https://t.co/HTX0fxFUM5
10.
DrBonillaOnc
RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab +nivolumab In Previously Untreated Metastatic… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
25 Mar 21 copy & paste +upvote -downvote 🚨⭐️RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab +nivolumab In Previously Untreated Metastatic… https://t.co/LQRx8WM7wa

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
https://www.iemoji.com/feed/DrBonillaOnc
Back to top